Team

Lead Scientist, Cancer PEP

Dr. Gabriela Ilie, PhD, Scientist in Cancer Quality of Life Research, Scientific Lead Cancer PEP and Prostate Cancer Patient Empowerment Program (PC-PEP)

Dr. Gabriela Ilie is a Dalhousie Faculty of Medicine Endowed Scientist in Prostate Cancer Quality of Life and an Associate Professor in the Departments of Community Health and Epidemiology, Urology, Radiation Oncology and Psychology, and Neuroscience at Dalhousie University. She is Affiliated Scientist with Nova Scotia Health Authority, Queen Elizabeth II Health Sciences Center and Scientist with the Beatrice Cancer Research Institute.  Gabriela initiated and leads the PC-PEP, CancerPEP and now Pictou County PEP Programs and the scientific and clinical teams behind these programs. Dr. Ilie has an established track record of publications with 99 papers (H index 25, i10 index 45; 4900+ lifetime citations. Her work appeared in highly ranked journals such as the European Urology, JAMA, American Journal of Men’s Health, BMJ Open, Psycho-oncology, and others. Dr. Ilie presents her work regularly at national and world congresses and gives yearly over 30 public talks.

Clinical Lead, Cancer PEP

Dr. Rob Rutledge, MD, Radiation Oncologist, Clinical Lead for the Cancer PEP and Prostate Cancer Patient Empowerment Program (PC-PEP)

Dr. Rob Rutledge is a Radiation Oncologist with Nova Scotia Health Authority, and Queen Elizabeth II Health Sciences Center, in Halifax, Nova Scotia who treats Prostate, Breast, and Peadiatric cancers. He is the Clinical Lead for the PC-PEP program. Over the past 27 years, Rob has dedicated himself to delivering numerous free public talks, webinars, and charity-led initiatives. He has organized and led 60 weekend retreats across 30 cities worldwide, as well as conducted dozens of day-long healing seminars for patients and medical professionals. Dr. Rutledge has an established track record of publications with 59 papers (H index 13, i10 index 16; 500+ lifetime citations. Her work appeared in highly ranked journals such as the European Urology, Lancet, American Journal of Men’s Health, Psycho-oncology, Cancers, Current Oncology, and others.